Evaluation of methods for measuring cellular glutathione content using flow cytometry.
The currently available flow cytometric stains for cellular glutathione were evaluated, examining the labelling of both human and rodent cell lines under various conditions of concentration, time, and temperature. Procedures were used that depleted glutathione (GSH) while having a minimal effect on other cellular sulphydryls in order to estimate linearity and the extent of background staining. As previously reported, monochlorobimane was highly specific for GSH in rodent cells but failed to label human cells adequately because of its low affinity for human glutathione S-transferases. Higher concentrations of monochlorobimane achieved more complete labelling of the human cellular GSH pool but gave increased background fluorescence due to non-GSH binding. The analogue monobromobimane, which binds nonenzymatically to sulphydryls, reacted more readily with GSH than with protein sulphydryls and, provided that stain concentration and incubation time were controlled, gave reproducible staining of human cells with approximately 20% of total fluorescence due to background staining. Of the currently available stains for measuring GSH in human cells, monobromobimane is the agent of choice. Mercury orange also binds more readily to GSH than to protein, giving a degree of specificity, and it has the additional advantage of being excited at 488 nm. However, the reproducibility of staining with mercury orange was less consistent than that using monobromobimane, and a higher background fluorescence was seen. Two additional stains, o-phthaldialdehyde and chloromethyl fluorescein, could also be used to label cellular GSH, but both gave an unacceptably high level of background staining. It is recommended that flow cytometric GSH assays should routinely include a sample of cells that have been depleted of GSH in order to determine the extent of background labeling.
Department of Pathology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Canada.
D W
DW
Hedley
S
S
Chow
D000818:Animals; D001943:Breast Neoplasms / Q000737:chemistry / Q000473:pathology; D001643:Bridged Bicyclo Compounds; D019328:Buthionine Sulfoximine; D016466:CHO Cells / Q000737:chemistry; D002277:Carcinoma / Q000737:chemistry / Q000473:pathology; D002296:Carcinosarcoma / Q000737:chemistry / Q000473:pathology; D003110:Colonic Neoplasms / Q000737:chemistry / Q000473:pathology; D006224:Cricetinae; D005033:Ethylmaleimide / Q000494:pharmacology; D005057:Eukaryotic Cells / Q000737:chemistry* / Q000187:drug effects; D005069:Evaluation Studies as Topic; D005434:Flow Cytometry / Q000379:methods*; D005452:Fluoresceins; D005456:Fluorescent Dyes; D005978:Glutathione / Q000032:analysis*; D006801:Humans; D008298:Maleates / Q000494:pharmacology; D008325:Mammary Neoplasms, Experimental / Q000737:chemistry / Q000473:pathology; D008717:Methionine Sulfoximine / Q000031:analogs & derivatives / Q000494:pharmacology; D051379:Mice; D010663:Phenylmercury Compounds; D011720:Pyrazoles; D013045:Species Specificity; D014407:Tumor Cells, Cultured; D001749:Urinary Bladder Neoplasms / Q000737:chemistry / Q000473:pathology; D009764:o-Phthalaldehyde
D001643:Bridged Bicyclo Compounds; D005452:Fluoresceins; D005456:Fluorescent Dyes; D008298:Maleates; D010663:Phenylmercury Compounds; D011720:Pyrazoles; C069306:5-chloromethylfluorescein; D008717:Methionine Sulfoximine; D019328:Buthionine Sulfoximine; D009764:o-Phthalaldehyde; C059597:monochlorobimane; C014476:diethyl maleate; D005978:Glutathione; D005033:Ethylmaleimide; C028381:monobromobimane; C031504:mercury orange